Rethinking future workforce planning by developing novel metrics of complexity in cancer care.

P Philip Q. Ding (Oncology Outcomes (O2), University of Calgary, Calgary, AB, Canada) M Matthew T. Warkentin (Oncology Outcomes (O2), University of Calgary, Calgary, AB, Canada) W Winson Y. Cheung (Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada)

Abstract

9015 Background: The decision to recruit additional oncologists is often based on simple workload measures such as new patient volumes. This approach may be appropriate previously when cancer management was less complex and at a time when attrition from cancer mortality was significant. We hypothesized that cancer care complexity has increased over time and that new metrics are needed to optimize workforce planning. Methods: We conducted a population-based, retrospective cohort study of adult patients diagnosed with common solid and blood cancers in Alberta, Canada. We focused on cases from 2004 to 2018 to ensure adequate follow-up. We evaluated indicators of complexity including patient characteristics at the time of diagnosis, clinical course within 2 years of diagnosis, and longevity as measured by overall survival (OS). For these complexity indicators, we used logistic and Cox regression models to estimate relative changes over the 15-year study period. Results: A total of 141,040 patients were included in the study cohort, with a median age of 66 years (range 18-107) and 51.7% male. Breast cancer was most common (25.6%), followed by prostate (24.0%), lung (20.2%), colorectal (17.9%) and leukemia/lymphoma (12.4%). Across all sites, annual cancer incidence rate was 249.9 per 100,000 in 2004 and 284.4 per 100,000 in 2018. Age distribution remained largely stable throughout the study period. Meanwhile, specific indicators of complexity increased over time, including polypharmacy at diagnosis (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.28-1.32), multimodality treatment (OR 1.06, 95% CI 1.05-1.08), and hospital admission via the emergency department (OR 1.08, 95% CI 1.07-1.10). These metrics also demonstrated increasing complexity in multivariable analyses after adjusting for age, sex, and cancer site. Similarly, there was a trend towards greater longevity as measured by OS (hazard ratio 0.98, 95% CI 0.98-0.98). Conclusions: Cancer care complexity has increased over time. Workforce planning using antiquated workload metrics, such as incident patient volumes alone, may not align with the actual demands of providing increasingly complex cancer care. Recruitment strategies should consider multi-faceted indicators that reflect complexity in addition to quantity. Trends in metrics of patient complexity, by time era. Characteristic Year of diagnosis 2004-2008, n = 39,465 2009-2013 , n = 46,408 2014-2018 , n = 55,167 Age, y (range) 66 (18, 104) 66 (18, 104) 66 (18, 107) Stage III-IV a 12,706 (41.4%) 15,265 (39.2%) 17,258 (38.1%) Polypharmacy 6,853 (17.4%) 11,175 (24.1%) 14,836 (26.9%) Multimodality treatment 13,884 (35.2%) 17,069 (36.8%) 21,025 (38.1%) Any admission via ED b 7,679 (19.5%) 9,341 (20.1%) 12,057 (21.9%) 2-year OS (95% CI) 0.70 (0.69-0.70) 0.73 (0.73-0.74) 0.76 (0.75-0.76) a solid cancers only; b within 2 years following diagnosis.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 9015-9015
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

P

Philip Q. Ding

Oncology Outcomes (O2), University of Calgary, Calgary, AB, Canada

M

Matthew T. Warkentin

Oncology Outcomes (O2), University of Calgary, Calgary, AB, Canada

W

Winson Y. Cheung

Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada